BioAtla, Inc. (BCAB) Tops Q1 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.48), $0.06 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• What Delta’s report tells investors in American and United
• Financial Select Sector SPDR ETF (XLF) spreader of 20K contracts of July 31 weekly 57 and 59 calls into bank earnings season